130 related articles for article (PubMed ID: 28877096)
1. Clinical Parameter for Deciding the BRAFV600E Mutation Test in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Thyroid Nodules: US Features According to TIRADS.
Rho M; Kim EK; Moon HJ; Yoon JH; Park VY; Han K; Kwak JY
Ultrasound Q; 2017 Dec; 33(4):284-288. PubMed ID: 28877096
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract][Full Text] [Related]
3. The combination of BRAF
Li Q; Yang L; Lv J; Xu L; Zhang M; Li S
Endocrine; 2022 Dec; 78(3):507-516. PubMed ID: 36152114
[TBL] [Abstract][Full Text] [Related]
4. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
Hong HS; Lee JY
AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
[No Abstract] [Full Text] [Related]
6. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
Choi SH; Baek JH; Lee JH; Choi YJ; Song DE; Chung KW; Kim TY; Shong YK
Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
[TBL] [Abstract][Full Text] [Related]
7. Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis.
Jeong SH; Hong HS; Lee EH; Cha JG; Park JS; Kwak JJ
AJR Am J Roentgenol; 2013 Dec; 201(6):W854-60. PubMed ID: 24261392
[TBL] [Abstract][Full Text] [Related]
8. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of Thyroid Imaging Reporting and Data System in the prediction of malignancy in nodules with atypia and follicular lesion of undetermined significance cytologies.
Baser H; Cakir B; Topaloglu O; Alkan A; Polat SB; Dogan HT; Yazicioğlu MO; Aydin C; Ersoy R
Clin Endocrinol (Oxf); 2017 Apr; 86(4):584-590. PubMed ID: 27911001
[TBL] [Abstract][Full Text] [Related]
11. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
Suh YJ; Choi YJ
Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204
[TBL] [Abstract][Full Text] [Related]
12. Web-based thyroid imaging reporting and data system: Malignancy risk of atypia of undetermined significance or follicular lesion of undetermined significance thyroid nodules calculated by a combination of ultrasonography features and biopsy results.
Choi YJ; Baek JH; Shin JH; Shim WH; Kim SO; Lee WH; Song DE; Kim TY; Chung KW; Lee JH
Head Neck; 2018 Sep; 40(9):1917-1925. PubMed ID: 29756265
[TBL] [Abstract][Full Text] [Related]
13. American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
Wu H; Zhang B; Cai G; Li J; Gu X
PLoS One; 2019; 14(7):e0219383. PubMed ID: 31295281
[TBL] [Abstract][Full Text] [Related]
14. An economically efficient strategy for diagnosing atypia of undetermined significance or follicular lesion of undetermined significance thyroid nodules with ultrasound-based risk stratification systems and
Ma X; Huang Y; Shen R; Cui Y; Kang Y; Yu J; Cui K
Quant Imaging Med Surg; 2024 Jan; 14(1):920-931. PubMed ID: 38223096
[TBL] [Abstract][Full Text] [Related]
15. Subcategorization of Bethesda System Category III by Ultrasonography.
Lee S; Shin JH; Oh YL; Hahn SY
Thyroid; 2016 Jun; 26(6):836-42. PubMed ID: 27094511
[TBL] [Abstract][Full Text] [Related]
16. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
[TBL] [Abstract][Full Text] [Related]
17. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
19. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
[TBL] [Abstract][Full Text] [Related]
20. RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?
Yoon JH; Kwon HJ; Lee HS; Kim EK; Moon HJ; Kwak JY
Medicine (Baltimore); 2015 Jul; 94(27):e1084. PubMed ID: 26166089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
